Clinical Trial Update: Effect of Adjunctive Misoprostol Treatment on Blood Loss at Vaginal Delivery [NA]

View source ↗

Summary

Clinical trial evaluating adjunctive misoprostol to reduce blood loss at vaginal delivery in postpartum hemorrhage; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postpartum Hemorrhage

Drugs mentioned

• MISOPROSTOL (Misoprostol)

Snippet

Sponsor: New York City Health and Hospitals Corporation | Conditions: Postpartum Hemorrhage | NA | Status: COMPLETED | Results posted: 2021-09-30